News & Updates

Cognition assessment important to ensure patient adherence to MS therapy
Cognition assessment important to ensure patient adherence to MS therapy
03 Aug 2022

Adherence to disease-modifying therapies (DMT) in multiple sclerosis (MS) is dependent not only on the properties of the medications themselves, but also on the capacities of the patient, a recent study has found.

Cognition assessment important to ensure patient adherence to MS therapy
03 Aug 2022
VTE prevention in pregnancy: Does heparin dose matter?
VTE prevention in pregnancy: Does heparin dose matter?
02 Aug 2022 byRoshini Claire Anthony

In pregnant women with a history of venous thromboembolism (VTE), receipt of low-molecular-weight heparin (LMWH) at either a weight-adjusted intermediate-dose or fixed low-dose during the antepartum and postpartum periods results in similar VTE incidence, according to findings of the Highlow study. However, there was a numerically lower incidence of VTE during the postpartum period with intermediate-dose LMWH.

VTE prevention in pregnancy: Does heparin dose matter?
02 Aug 2022
Low-intensity shock wave safe, effective on moderate erectile dysfunction
Low-intensity shock wave safe, effective on moderate erectile dysfunction
02 Aug 2022

Men with moderate erectile dysfunction (ED) may benefit from having 12 sessions of low-intensity shock wave therapy (SWT) twice weekly for 6 weeks, with a treatment protocol of 5,000 impulses, 0.0096 mJ/mm2 energy flux density, and 5-Hz frequency, suggests a study.

Low-intensity shock wave safe, effective on moderate erectile dysfunction
02 Aug 2022